MX9305933A - Metodo para antagonizar al 1,4,5-trifosfato de inositol. - Google Patents
Metodo para antagonizar al 1,4,5-trifosfato de inositol.Info
- Publication number
- MX9305933A MX9305933A MX9305933A MX9305933A MX9305933A MX 9305933 A MX9305933 A MX 9305933A MX 9305933 A MX9305933 A MX 9305933A MX 9305933 A MX9305933 A MX 9305933A MX 9305933 A MX9305933 A MX 9305933A
- Authority
- MX
- Mexico
- Prior art keywords
- inositol
- triphosphate
- antagonize
- oligometers
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/795—Polymers containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
La invención proporciona oligómetros de la fórmula (ver fórmula I) que han demostrado ser antagonistas efectivos del 1,4,5-trifosfato de inositol (IP3) compitiendo con IP3 por los sitios de enlace. Al inhibir competitivamente la actividad del IP3, los oligómetros de esta invención puede modular la liberación de calcio intracelular y producir los efectos fisiológicos resultantes.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95239392A | 1992-09-28 | 1992-09-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9305933A true MX9305933A (es) | 1994-04-29 |
Family
ID=25492868
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9305933A MX9305933A (es) | 1992-09-28 | 1993-09-27 | Metodo para antagonizar al 1,4,5-trifosfato de inositol. |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0661982A1 (es) |
JP (1) | JPH08502068A (es) |
KR (1) | KR950703347A (es) |
AU (1) | AU670962B2 (es) |
CA (1) | CA2145681A1 (es) |
HU (1) | HUT70192A (es) |
IL (1) | IL107066A (es) |
MX (1) | MX9305933A (es) |
NO (1) | NO951163L (es) |
NZ (1) | NZ256178A (es) |
TW (1) | TW260663B (es) |
WO (1) | WO1994007507A1 (es) |
ZA (1) | ZA936978B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2978995A (en) * | 1994-06-30 | 1996-01-25 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Methods for treating cell proliferative disorders by modulating signal transduction |
EP0809492A4 (en) | 1995-02-17 | 2007-01-24 | Smithkline Beecham Corp | IL-8 RECEPTOR ANTAGONISTS |
US5780483A (en) * | 1995-02-17 | 1998-07-14 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
US6083920A (en) * | 1995-12-21 | 2000-07-04 | Ayurcore, Inc. | Compositions for modulating intracellular inositol trisphosphate concentration |
US6005008A (en) * | 1996-02-16 | 1999-12-21 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
US6211373B1 (en) | 1996-03-20 | 2001-04-03 | Smithkline Beecham Corporation | Phenyl urea antagonists of the IL-8 receptor |
US6262113B1 (en) | 1996-03-20 | 2001-07-17 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
US6133319A (en) * | 1996-06-27 | 2000-10-17 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
EP0915651A4 (en) | 1996-06-27 | 2001-10-24 | Smithkline Beecham Corp | IL-8 RECEPTOR ANTAGONISTS |
ATE358486T1 (de) * | 2000-11-09 | 2007-04-15 | Contrimmune Biotechnology Inc | Verwendung von xestospongin c zur behandlung oder vorbeugung einer hiv-infektion |
JP2014531425A (ja) | 2011-09-02 | 2014-11-27 | ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク | 肥満の代謝異常を治療するためのCaMKII、IP3R、カルシニューリン、p38、およびMK2/3阻害剤 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB781479A (en) * | 1953-08-27 | 1957-08-21 | Ciba Ltd | New polyureas and process for making them |
US5276182A (en) * | 1990-07-09 | 1994-01-04 | The Dow Chemical Company | Process for preparing polyurea oligomers |
-
1993
- 1993-08-30 WO PCT/US1993/008168 patent/WO1994007507A1/en not_active Application Discontinuation
- 1993-08-30 CA CA002145681A patent/CA2145681A1/en not_active Abandoned
- 1993-08-30 AU AU48417/93A patent/AU670962B2/en not_active Ceased
- 1993-08-30 JP JP6509054A patent/JPH08502068A/ja active Pending
- 1993-08-30 HU HU9500891A patent/HUT70192A/hu unknown
- 1993-08-30 NZ NZ256178A patent/NZ256178A/en unknown
- 1993-08-30 EP EP93921252A patent/EP0661982A1/en not_active Ceased
- 1993-08-30 KR KR1019950701166A patent/KR950703347A/ko not_active Application Discontinuation
- 1993-09-21 ZA ZA936978A patent/ZA936978B/xx unknown
- 1993-09-22 IL IL107066A patent/IL107066A/en not_active IP Right Cessation
- 1993-09-22 TW TW082107787A patent/TW260663B/zh active
- 1993-09-27 MX MX9305933A patent/MX9305933A/es unknown
-
1995
- 1995-03-27 NO NO951163A patent/NO951163L/no unknown
Also Published As
Publication number | Publication date |
---|---|
IL107066A0 (en) | 1993-12-28 |
ZA936978B (en) | 1994-04-18 |
NO951163D0 (no) | 1995-03-27 |
JPH08502068A (ja) | 1996-03-05 |
CA2145681A1 (en) | 1994-04-14 |
WO1994007507A1 (en) | 1994-04-14 |
AU4841793A (en) | 1994-04-26 |
HU9500891D0 (en) | 1995-05-29 |
EP0661982A1 (en) | 1995-07-12 |
HUT70192A (en) | 1995-09-28 |
IL107066A (en) | 1998-01-04 |
TW260663B (es) | 1995-10-21 |
KR950703347A (ko) | 1995-09-20 |
AU670962B2 (en) | 1996-08-08 |
NO951163L (no) | 1995-03-27 |
NZ256178A (en) | 1997-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE179892T1 (de) | Verwendung von lipid-gebundener glykoaminoglykanen zur behandlung der rheumatoider arthritis | |
MX9305933A (es) | Metodo para antagonizar al 1,4,5-trifosfato de inositol. | |
ATE206919T1 (de) | Verwendung des wirkstoffs flupirtin zur herstellung eines arzneimittels zur bekämpfung von muskelverspannungen | |
BR0116001A (pt) | Métodos para tratar distúrbios neuropsiquiátricos com antagonistas receptores nmda | |
ES2108120T3 (es) | Compuestos bis arilicos y heteroarilicos mono- y biciclicos que inhiben tirosina quinasa receptora de egf y/o pdgf. | |
DE69022953T2 (de) | Zusammensetzungen zur Behandlung von Fettablagerungen. | |
PT729468E (pt) | Antagonistas nao peptidicos de receptores de taquiquininas | |
GB9514451D0 (en) | Sustained-release formulation | |
PA8443001A1 (es) | Prevencion de la perdida y restauracion de la masa osea por determinados agonistas de prostaglandinas | |
DE69113029D1 (de) | Verwendung von vitamin-d-analoga zur behandlung von akne. | |
IL86951A0 (en) | Methylene phosphonoalkylphosphinates and pharmaceutical compositions containing them | |
GB2223169B (en) | Inositol trisphosphate for the treatment of bone disorders | |
IT1247796B (it) | Derivati arilvinilamidici e procedimento per la loro preparazione | |
DE69230224T2 (de) | Potenzierung von nmda-antagonisten | |
SE9303853D0 (sv) | The use of an ester of inositoltrisphosphate for the preparing of medicaments | |
SE9404568D0 (sv) | The use of inositoltrisphosphate for the preparing of medicaments | |
MX9305914A (es) | 2-arilpirroles, procedimiento para su preparacion y agentes pesticidas quelos contienen. | |
MX166685B (es) | Proceso para la preparacion de alcanosulfonamidas y arenosulfonamidas | |
DE69424747D1 (de) | Pharmazeutische Zusammensetzung zur Vorbeugung oder Behandlung von Knochenbrüchen | |
ES2095985T3 (es) | Analogos de fosfato de inositol como sustancias antagonistas del calcio. | |
AR007046A1 (es) | Compuestos de quinazolina utiles para combatir hongos y animales daninos; composiciones que los contienen, procedimiento para preparar dichoscompuestos; compuestos intermediarios de aplicacion en la preparacion de dichos compuestos y utilizacion de dichos compuestos en la preparacion de dichas | |
AR013927A1 (es) | Mezclas fungicidas, procedimiento para controlar hongos nocivos con dichas mezclas, uso de los componentes activos para prepararlas y el producto formulado en dos partes que contiene los componentes activos i.d y ii separados. | |
DE69932434D1 (de) | Prophylaxe und Behandlung von autoimmunen Entmyelinisierungserkrankungen durch Fas-antagonisten | |
NO921525L (no) | L-alfa-glyserofosforyl-d-myo-inositol for behandling av perifere nervelidelser og hjernelidelser | |
SE9303289D0 (sv) | The use of inositoltrisphosphate for the preparing of medicaments |